GM Advisory Group Inc. bought a new position in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,346 shares of the conglomerate’s stock, valued at approximately $218,000.
A number of other large investors have also bought and sold shares of the stock. TIAA FSB acquired a new position in shares of Danaher in the 2nd quarter worth approximately $8,450,000. Woodley Farra Manion Portfolio Management Inc. lifted its position in shares of Danaher by 3.4% in the 2nd quarter. Woodley Farra Manion Portfolio Management Inc. now owns 288,672 shares of the conglomerate’s stock worth $24,361,000 after purchasing an additional 9,581 shares during the period. California Public Employees Retirement System lifted its position in shares of Danaher by 3.3% in the 2nd quarter. California Public Employees Retirement System now owns 1,260,999 shares of the conglomerate’s stock worth $106,416,000 after purchasing an additional 40,000 shares during the period. Wealthfront Inc. lifted its position in shares of Danaher by 10.2% in the 2nd quarter. Wealthfront Inc. now owns 14,574 shares of the conglomerate’s stock worth $1,230,000 after purchasing an additional 1,348 shares during the period. Finally, WESPAC Advisors SoCal LLC lifted its position in shares of Danaher by 1.2% in the 2nd quarter. WESPAC Advisors SoCal LLC now owns 4,060 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 50 shares during the period. Institutional investors and hedge funds own 77.05% of the company’s stock.
A number of research analysts have recently issued reports on DHR shares. Credit Suisse Group restated a “hold” rating and issued a $99.00 price target on shares of Danaher in a research report on Tuesday, December 19th. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Robert W. Baird restated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Royal Bank of Canada restated a “hold” rating and issued a $96.00 price target on shares of Danaher in a research report on Thursday, January 4th. Finally, Evercore ISI started coverage on shares of Danaher in a research report on Wednesday, January 3rd. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $100.68.
Shares of Danaher Co. (DHR) opened at $97.54 on Tuesday. The firm has a market cap of $67,946.36, a price-to-earnings ratio of 27.63, a PEG ratio of 2.05 and a beta of 1.04. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05. Danaher Co. has a one year low of $78.97 and a one year high of $104.82.
Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. The company had revenue of $5.09 billion during the quarter, compared to analyst estimates of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. Danaher’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.05 EPS. analysts expect that Danaher Co. will post 4.37 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were paid a $0.14 dividend. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.57%. Danaher’s dividend payout ratio is currently 15.86%.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the sale, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP William K. Daniel sold 131,066 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the sale, the executive vice president now owns 270,523 shares of the company’s stock, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. Insiders sold a total of 237,043 shares of company stock valued at $24,194,886 in the last quarter. 12.20% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: “GM Advisory Group Inc. Takes Position in Danaher Co. (DHR)” was reported by Stock Observer and is owned by of Stock Observer. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.thestockobserver.com/2018/02/20/gm-advisory-group-inc-takes-position-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.